Chrysanthemum cinerariaefolium extract from open and mature flowers of Tanacetum cinerariifolium obtained with supercritical carbon dioxide has been approved as an active substance for use in biocidal products of type 19 (PT1) – Repellents in accordance with Regulation (EU) no. 528/2012 of the European Parliament and the Council.
By January 1, 2024, all manufacturers of biocidal products containing Chrysanthemum cinerariaefolium Extract must submit an application for authorization if they wish to continue selling their products.
You can read more about authorization procedures here.
Despite the seemingly distant date, the time to act is today, as the preparation of an extensive dossier requires time. If you have any questions or need advice, you can contact us, where we will be happy to help you.
Tel. +386 40 612 539